The Motley Fool
03 May 2026, 12:30 UTC · 27w ago
2 Medical Marijuana Stocks to Buy Now
Impact · against what's priced in
The DOJ's reclassification of cannabis to Schedule III provides a material catalyst for TCNNF and GTBIF by removing the 280E tax burden. This shift is expected to drastically lower Trulieve's effective tax rate from 60-70% to 21%, directly boosting net profitability and cash flow.
- TCNNF+0.60
No priced-in read yet
- In context
The removal of IRS Code Section 280E is expected to lower Trulieve's effective tax rate from 60%-70% to approximately 21%, significantly increasing net profitability.
Read from the article alone
